sur SARTORIUS STED BIO (EPA:DIM)
Sartorius Stedim Biotech Announces Share and Voting Rights Update
Sartorius Stedim Biotech SA has made a formal declaration regarding the number of shares and voting rights constituting its issued capital. This announcement, disseminated by EQS Group on August 2, 2024, provides key data as per French regulations.
As of July 31, 2024, Sartorius Stedim Biotech's total issued capital comprises 97,330,405 shares. The total number of theoretical voting rights, including treasury shares, stands at 165,568,221. The net voting rights, excluding treasury shares, slightly differ, totaling 165,541,761.
These figures are in accordance with Article L 233-8-II of the French Code of Commerce and Article 223-6 of the AMF's general regulations. This activity ensures compliance and provides transparency to stakeholders.
R. H.
Copyright © 2024 FinanzWire, tous droits de reproduction et de représentation réservés.
Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.
Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève
Voir toutes les actualités de SARTORIUS STED BIO